Minimal residual disease (MRD) detection in colorectal cancer (CRC) using a plasma-only integrated genomic and epigenomic circulating tumor DNA (ctDNA) assay

被引：1
|
作者：
Parikh, A. [1 ]
van Seventer, E. [2 ]
Boland, G. [1 ]
Siravegna, G. [1 ]
Hartwig, A. [3 ]
Jaimovich, A. [4 ]
Raymond, V. M. [5 ]
Talasaz, A. [6 ]
Corcoran, R. B. [7 ]
机构：
[1] Massachusetts Gen Hosp, Hematol Oncol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA
[3] Guardant Hlth Inc, Res & Dev, Redwood City, CA USA
[4] Guardant Hlth Inc, Bioinformat, Redwood City, CA USA
[5] Guardant Hlth Inc, Med Affairs, Redwood City, CA USA
[6] Guardant Hlth Inc, Redwood City, CA USA
[7] MGH Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.530
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
419P
引用
收藏
页码：S419 / S419
页数：1
相关论文
共 50 条
  • [41] Clinical experience of a personalized and tumor-informed circulating tumor DNA assay for minimal residual disease detection in oligometastatic colorectal cancer patients
    Cohen, S.
    Hook, N.
    Krinshpun, S.
    Westbrook, L.
    Loranger, K.
    Wallace, J.
    Aleshin, A.
    Billings, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S229 - S229
  • [42] A retrospective study of circulating tumor DNA for minimal residual disease detection in the management of colorectal cancer.
    Storandt, Michael H.
    Emiloju, Oluwadunni Eunice
    Zemla, Tyler J.
    McWilliams, Robert R.
    Sinicrope, Frank A.
    Mitchell, Jessica L.
    Shi, Qian
    Jin, Zhaohui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 227 - 227
  • [43] The Method of Minimal Residual Disease Detection With Circulating Tumor DNA and Its Clinical Applications in Colorectal Cancer
    Liu, Ming
    Mu, Tianhao
    Gu, Jia
    Xu, Mingyan
    Chen, Shifu
    CANCER REPORTS, 2025, 8 (03)
  • [44] Circulating tumor DNA for detection of molecular residual disease (MRD) in patients (pts) with stage II/III colorectal cancer (CRC): Final analysis of the BESPOKE CRC sub-cohort.
    Shah, Purvi K.
    Aushev, Vasily N.
    Ensor, Joe
    Sanchez, Stephanie A.
    Wang, Christopher Gene
    Cannon, Timothy Lewis
    Berim, Lyudmyla Derby
    Feinstein, Trevor
    Grothey, Axel
    McCollom, Joseph William
    Kalmadi, Sujith R.
    Zakari, Ahmed
    Dayyani, Farshid
    Gravenor, Don
    Liu, Minetta C.
    Jurdi, Adham A.
    Aleshin, Alexey
    Meyer, Janelle Marie
    Sharif, Saima
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 15 - 15
  • [45] Enhanced detection of molecular residual disease (MRD) by tumor-informed and tumor-agnostic variants in circulating tumor DNA (ctDNA)
    Yan, Xiaoluan
    Li, Zhencong
    Wang, YanYan
    Li, Juan
    Liu, Ming
    Wang, Hongwei
    Jin, Kemin
    Bao, Quan
    Wang, Lijun
    Liu, Wei
    Liu, Lijuan
    Da, Xu
    Hu, Yifan
    Zhang, Yiqun
    Zang, Yuehua
    Pei, Zhihua
    Wang, Dongliang
    Zhou, Qiming
    Xing, Baocai
    Wang, Kun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] PLASMA BASED CELL-FREE CIRCULATING TUMOR DNA (CTDNA) ASSESSMENT FOR NON-INVASIVE DETECTION OF COLORECTAL CANCER (CRC)
    Dean, Jason
    He, Yupeng
    Raymond, Victoria
    Kim, Seung Tae
    Lee, Jeeyun
    Kim, Hee Cheol
    Jaimovich, Ariel
    Talasaz, AmirAli
    GASTROENTEROLOGY, 2020, 158 (06) : S369 - S369
  • [47] Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection
    Xu, Yuyan
    Cai, Jianpeng
    Zhong, Kaihang
    Wen, Yaohong
    Cai, Lei
    He, Guolin
    Liao, Hangyu
    Zhang, Cheng
    Fu, Shunjun
    Chen, Tingting
    Cai, Jinping
    Zhong, Xuefeng
    Chen, Chunzhu
    Huang, Mengli
    Cheng, Yuan
    Pan, Mingxin
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [48] Molecular residual disease (MRD) detection using bespoke circulating tumor DNA (ctDNA) assays in localized soft tissue sarcoma (STS)
    Salawu, Abdulazeez
    Demicco, Elizabeth
    Chung, Peter W. M.
    Feeney, Jordan
    Spickard, Erik
    Rathore, Richa
    Lee, Jasmine
    Wong, Philip
    Malone, Eoghan Ruadh
    Catton, Charles
    Arones, Limore
    Phillips, Madeline J.
    Ferguson, Peter Charles
    Wunder, Jay
    Tin, Tony
    Sethi, Himanshu
    Liu, Minetta C.
    Shultz, David Benjamin
    Razak, Albiruni Ryan Abdul
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] Analysis of ctDNA for the detection of minimal residual disease (MRD) using a tissue-free, epigenomic assay in patients with early-stage breast cancer - results from the Success A study
    Friedl, Thomas W. P.
    Rack, Brigitte
    Fasching, Peter Andreas
    Hartkopf, Andreas
    Tesch, Hans
    Lorenz, Ralf
    Heinrich, Georg
    Blohmer, Jens-Uwe
    Fehm, Tanja
    Mueller, Volkmar
    Schneeweiss, Andreas
    Beckmann, Matthias
    Ruebner, Matthias
    Harbeck, Nadia
    Pantel, Klaus
    Dustin, Derek
    Cai, Mingyang
    Janni, Wolfgang
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 261 - 261
  • [50] Sequencing paired tumor DNA and white blood cells (WBCs) increases sensitivity to track plasma circulating tumor DNA (ctDNA) for detecting minimal residual disease (MRD) in localized colon cancer (CC)
    Tarazona, N.
    Martin-Arana, J.
    Tebar-Martinez, R.
    Lombardi, P.
    Moragon, S.
    Zuniga, S.
    Rentero-Garrido, P.
    Carbonell-Asins, J. A.
    Gambardella, V.
    Huerta, M.
    Rosello, S.
    Martinez-Ciarpaglini, C.
    Alfaro-Cervello, C.
    Moro, D.
    Ferrer-Martinez, A.
    Ponce, M.
    Pena, A.
    Espi, A.
    Roda, D.
    Cervantes, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S413 - S414
12345